Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MILTEFOSINE
- Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis
- Treatment of Mucosal Bolivian Leishmaniasis
- Combination, Miltefosine Monotherapy & Antimonial Therapy for Cutaneous Leishmaniasis in New World
- Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis.
- Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
- Miltefosine Plus IL Pentamidine for Bolivian CL
- Short Course Regimens for Treatment of PKDL (Sudan)
- Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
- Miltefosine and GM-CSF in Cutaneous Leishmaniasis
- Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨
- The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil
- Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
- Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
- Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
- Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
- Miltefosine for Children With PKDL
- Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
- A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)
- Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)
- Pharmacokinetics of Miltefosine in Children and Adults
- Oral Miltefosine Plus Topical Imiquimod to Treat Cutaneous Leishmaniasis
- Treatment of Cutaneous Leishmaniasis With a Combination of Miltefosine and Antimony
- Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis
- Intralesional Antimony for Bolivian Cutaneous Leishmaniasis
- A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies
- Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria
- Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh
- Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
- Miltefosine to Treat Mucocutaneous Leishmaniasis
- Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
- Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
- Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
- Combination Therapy in Indian Visceral Leishmaniasis
- Oral Miltefosine for the Treatment of Pediatric Cutaneous Leishmaniasis in Colombia
- Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.
- Miltefosine for Brazilian Visceral Leishmaniasis
- Miltefosine for Mucosal Leishmaniasis
- Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
- Combination Chemotherapy for the Treatment of Indian Kala-Azar
- Efficacy Trial on Oral Miltefosine in Comparison With Glucantime in the Treatment of ACL Caused by L. Tropica
- Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis
- Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
Clinical trials list
click for details